Detalhe da pesquisa
1.
The role of phosphatidylinositol 3-kinase-δ in the immunomodulatory effects of lenalidomide in chronic lymphocytic leukemia.
Blood
; 117(16): 4323-7, 2011 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-21378270
2.
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765.
Blood
; 117(23): 6287-96, 2011 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-21422473
3.
Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals.
Blood
; 116(12): 2078-88, 2010 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-20522708
4.
Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinib.
Blood Adv
; 1(19): 1584-1588, 2017 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29296799